Teriflunomide Safety and Efficacy in Advanced Progressive Multiple Sclerosis

Figure 2

Kaplan-Meier curve for the time to sustained expanded disability status scale (EDSS) progression. Red line represents glatiramer acetate; black line represents teriflunomide. -axis is the probability of remaining free of sustained progression on EDSS, and the -axis is the days since treatment initiation.